Use of Ziv Aflibercept in Different Retinal Diseases

NCT04290195 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Central Retinal Vein Occlusion With Macular Edema

Interventions

DRUG: Ziv-Aflibercept 25 MG/ML [Zaltrap]

Sponsor

Amin El Sayed Nawar

Collaborators

[object Object]